Back to search
FDAFDA · Food and drugs·Recall number D-0925-2023

Fingolimod Capsules, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-476-30.

Published July 26, 2023 · Recall initiated: July 11, 2023

Summary

FDA records drug Class II recall D-0925-2023, published July 26, 2023 and initiated July 11, 2023. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 2652 bottles; Lot: Lot 22122841, Exp August 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if FINGOLIMOD has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FINGOLIMOD
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide in the USA
Lot
Lot 22122841, Exp August 2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fingolimod Capsules, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-476-30. recalled?

Yes. FDA published recall D-0925-2023 on July 26, 2023. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FINGOLIMOD.